Clinical and cost effectiveness of arthritis gloves in rheumatoid arthritis (A-GLOVES): randomised controlled trial with economic analysis

Table 5 Results of incremental cost-effectiveness analysis for intervention versus control gloves

	Net cost (95% CI)	Net QALY (95% CI)	ICER (£/QALY)	Probability intervention is cost effective versus control if WTPT =
	Net cost (95% CI)	Net QALY (95% CI)	ICER (£/QALY)	£20,000/ QALY	£30,000/ QALY	£60,000/ QALY
Complete cases (ITT) (n = 151)	£251 (106, 396)	0.003 (−0.017, 0.023)	£83,700/QALY	0.19	0.29	0.44

Note: whole £ reported in table but ICERs calculated including pence
Covariates costs: pre-baseline costs, stratification variable
Covariates QALYs: baseline health status, stratification variable
ICER incremental cost-effectiveness ratio, WTPT willingness to pay threshold, ITT intention to treat
^aat different willingness to pay thresholds, based on 10,000 bootstrap simulations

ISSN: 1471-2474